- A new FDA-approved systemic treatment option
- The important role of multidisciplinary consultation in the management of advanced BCC
- Results and case studies from a prospective clinical study in locally advanced BCC patients
| To view this email as a web page, click here. |
|
| Please join us to learn about the multidisciplinary management of advanced BCC |
| Thursday, March 11 • 5:00 pm EST |
|
| Topics of discussion at this virtual event include: |
|
| Expert insights provided by: | |
 |
|
| Mark Agulnik, MD Section Chief, Sarcoma Oncology H&N Program City of Hope Medical Center Duarte, CA |
|
| Sponsored by | |
 |
|
| ONC.21.01.0014 2/21 | |
| In accordance with the PhRMA Code on Interactions with Healthcare Professional, this Program is limited to U.S. Healthcare Professionals and persons with bona fide professional interest in the information presented. No CME credits offered for attendance of this program. | |
 |
|